Award
Delivery Order #SPE2DP26F2963
Delivery Order for Loperamide Hydrochloride Under Pharmaceutical Supply Contract
Buyer
Defense Logistics Agency
Award Amount
$95.48
Ceiling
$95.48
Awarded
February 22, 2026
Period of Performance
Feb 22, 2026 – Feb 23, 2026
Identifier
SPE2DP26F2963
NAICS
424210
This award is a delivery order under a long-term definitive pharmaceutical supply contract previously awarded to DMS Pharmaceutical Group Inc., a distributor specializing in pharmaceutical products. The delivery order specifically covers the procurement of Loperamide Hydrochloride, a medication used to treat digestive conditions. This targeted order supports the broader scope of the master contract aimed at providing essential pharmaceuticals to federal health agencies, contributing to the reliable availability of critical drug inventories. The short-term performance period for this delivery order reflects a specific requisition within the ongoing supply framework. The contract is not sole-source; it is part of a strategic multi-year procurement ensuring consistent medical supply. The parent contract represents a significant commitment to healthcare provisioning with varied pharmaceutical products, underscoring the importance of this delivery order within that context.
Description
8511936299!LOPERAMIDE HYDROCHL